Medicine

Medicine

Julio Ramirez, M.D., right, in the UofL infectious diseases laboratory

Facing down infectious disease

Addressing the novel coronavirus global pandemic may be a recent challenge, but managing the impact of diseases threatening human health is nothing new for...
Immunomodulatory signal presentation via synthetic hydrogel material promotes generation of T regulatory cells (green) in the local graft microenvironment (CD3+ T cells in red, and nuclei staining in blue) after implantation into a clinically relevant transplant model for the treatment of type 1 diabetes. (Credit: Georgia Tech)

UofL-born technology for treating Type 1 diabetes has commercial partner

A University of Louisville-born therapy that helps people with Type 1 diabetes stay off immunosuppressants by re-educating the body’s immune system to accept transplanted...
Immunomodulatory signal presentation via synthetic hydrogel material promotes generation of T regulatory cells (green) in the local graft microenvironment (CD3+ T cells in red, and nuclei staining in blue) after implantation into a clinically relevant transplant model for the treatment of type 1 diabetes. (Credit: Georgia Tech)

UofL-born technology for treating Type 1 diabetes has commercial partner

LOUISVILLE, Ky. — A University of Louisville-born therapy that helps people with Type 1 diabetes stay off immunosuppressants by re-educating the body’s immune system...
PhD student Zach Whiddon

NIH funds UofL doctoral students’ work on taste buds and brain circuitry

You may be confident in your potential to pursue a career in biomedical research when the National Institutes of Health funds your work before...
UofL Trager Institute

UofL Trager Institute uses technology to reduce social isolation for older adults Initiatives to...

Amid efforts to stem the spread of the COVID-19 pandemic, social isolation and loneliness have emerged as a significant public health crisis, particularly for...
Map 2: Prevalence of COVID-19 in Jefferson County in June 2020.

Phase II results of Co-Immunity Project show higher-than-expected rates of coronavirus exposure in Jefferson...

Results from the second phase of the University of Louisville’s groundbreaking project to track COVID-19 in Jefferson County show that 4 to 6 times...

Phase II results of Co-Immunity Project show higher-than-expected rates of exposure to novel coronavirus...

LOUISVILLE, Ky. – Results from the second phase of the University of Louisville’s groundbreaking project to track COVID-19 in Jefferson County show that 4...
Geoffrey Clark, Ph.D.

UofL technology that may inhibit pathway for cancer gets commercial partner Researchers say the...

NA University of Louisville-born invention that may help treat cancer now has a commercial partner. Qualigen Therapeutics Inc., a California biotechnology company focused on developing...
Geoffrey Clark, Ph.D.

UofL technology that may inhibit pathway for cancer gets commercial partner Researchers say the...

LOUISVILLE, Ky. — A University of Louisville-born invention that may help treat cancer now has a commercial partner. Qualigen Therapeutics Inc., a California biotechnology company...
A clinical trial for Aviptadil (RLF-100) is underway at UofL for severe COVID-19 patients. Image courtesy NeuroRx.

UofL conducting clinical trial on drug for severe COVID-19 respiratory effects

The University of Louisville is conducting a clinical trial on a new treatment for critically ill COVID-19 patients meant to lessen some of the...